Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 1.545.163.901.571.23

What is the latest Working Capital/Sales ratio of ORCHID PHARMA ?

The latest Working Capital/Sales ratio of ORCHID PHARMA is 1.54 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.54
Mar20235.16
Mar20223.90
Mar20211.57
Mar20201.23

How is Working Capital/Sales of ORCHID PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 1.54
-70.16
Mar2023 5.16
32.31
Mar2022 3.9
148.41
Mar2021 1.57
27.64
Mar2020 1.23 -

Other Financial Ratios of ORCHID PHARMA


Compare Working Capital/Sales ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹7,828.8 Cr -3.7% -13.8% 124.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,715.0 Cr 0.3% -2.6% 36.7% Stock Analytics
DIVIS LABORATORIES ₹154,460.0 Cr -1% -0.5% 60.8% Stock Analytics
CIPLA ₹115,271.0 Cr -1.4% -3.1% 11.8% Stock Analytics
DR REDDYS LABORATORIES ₹107,511.0 Cr -3.8% -4% 15.3% Stock Analytics
ZYDUS LIFESCIENCES ₹99,189.5 Cr 0.1% 1.2% 40.3% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-3.7%

-13.8%

124.7%

SENSEX

-0.9%

-4.3%

3.7%


You may also like the below Video Courses